REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
XTX Topco Ltd 10,215$329,0250.07%
Capital World Investors 10,076,101$324,551,2130.07%
TWINBEECH CAPITAL LP 98,684$3,178,6120.06%
OCCUDO QUANTITATIVE STRATEGIES LP 21,918$705,9790.06%
SEVEN EIGHT CAPITAL, LP 8,909$286,9590.06%
PUBLIC SECTOR PENSION INVESTMENT BOARD 254,000$8,181,3400.06%
Caption Management, LLC 93,500$3,011,6350.06%
Engineers Gate Manager LP 40,684$1,310,4320.06%
NOTTINGHAM ADVISORS, INC. 12,179$392,2860.05%
AIGEN INVESTMENT MANAGEMENT, LP 11,838$381,3020.05%
Accredited Investors Inc. 20,491$660,0150.05%
JENNISON ASSOCIATES LLC 1,633,305$52,608,7570.05%
CENTAURUS FINANCIAL, INC. 15,881$5120.04%
Flaharty Asset Management, LLC 6,952$223,9240.04%
Centiva Capital, LP 50,000$1,610,5000.04%
BLAIR WILLIAM & CO/IL 306,877$9,884,5080.04%
FRANKLIN RESOURCES INC 2,274,491$73,261,3570.04%
Y-Intercept (Hong Kong) Ltd 10,009$322,3900.04%
Inspire Investing, LLC 8,464$272,6250.04%
PROFUND ADVISORS LLC 17,021$548,2460.03%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.